194 related articles for article (PubMed ID: 3496051)
21. [Chemotherapeutic strategy in rat brain tumor cells resistant to ACNU using an in vitro colony formation assay].
Mineura K; Sasaki J; Fushimi S; Sasajima H; Ishino Y; Kowada M
No To Shinkei; 1989 Sep; 41(9):927-32. PubMed ID: 2590562
[TBL] [Abstract][Full Text] [Related]
22. [Enhancing effect of reserpine upon the cytotoxicity of ACNU on ACNU-resistant glioma cells].
Yoshida T; Shimizu K; Ushio Y; Hayakawa T; Mogami H; Sakamoto Y
Neurol Med Chir (Tokyo); 1986 Dec; 26(12):925-30. PubMed ID: 2438568
[No Abstract] [Full Text] [Related]
23. [Effect of ACNU, a water-soluble nitrosourea, on cell cycle of cultured glioma cells--flow cytometric analysis].
Fujiwara T; Nakasone S; Matsumoto K; Ohnishi R; Tabuchi K; Nishimoto A
Gan To Kagaku Ryoho; 1983 Sep; 10(9):2055-61. PubMed ID: 6577816
[TBL] [Abstract][Full Text] [Related]
24. Significance of DNA cross-links on 1-(4-amino-2-methylpyrimidin-5-yl)methyl-3-(2-chloroethyl)-3- nitrosourea (ACNU)-induced cytotoxicity against ACNU-sensitive and -resistant lines of 9L rat glioma cells.
Kokunai T; Tamaki N; Matsumoto S
J Natl Cancer Inst; 1987 Jul; 79(1):119-22. PubMed ID: 3474438
[TBL] [Abstract][Full Text] [Related]
25. [Application of flow cytometry to the chemosensitivity test by the BrdU labeling method; a preliminary report].
Nomura K; Matsuoka K; Shibui S; Watanabe T; Nakamura O; Takakura K
Gan To Kagaku Ryoho; 1987 Mar; 14(3 Pt 1):668-73. PubMed ID: 2435247
[TBL] [Abstract][Full Text] [Related]
26. [Adoptive immunotherapy in patients with malignant glioma].
Yoshida S; Takai N; Saito T; Tanaka R
Gan To Kagaku Ryoho; 1987 Jun; 14(6 Pt 1):1930-2. PubMed ID: 3496052
[TBL] [Abstract][Full Text] [Related]
27. [Application of flow cytometry to chemotherapy of malignant brain tumor].
Nomura K; Shibui S; Watanabe T
Gan To Kagaku Ryoho; 1982 Jul; 9(7):1151-63. PubMed ID: 6191709
[TBL] [Abstract][Full Text] [Related]
28. [MCNU effectiveness on brain tumor. Part I: Antitumor activity in vitro on human glioma and neuroblastoma cell lines].
Wakabayashi T; Yoshida J; Inoue I; Kageyama N; Nagata M; Kanzaki M
Gan To Kagaku Ryoho; 1984 May; 11(5):1098-106. PubMed ID: 6586113
[TBL] [Abstract][Full Text] [Related]
29. [Experimental studies on induced hypertension chemotherapy of intracerebral inoculated gliomas in rats].
Tokuda K
Hokkaido Igaku Zasshi; 1986 Jul; 61(4):612-20. PubMed ID: 3463530
[TBL] [Abstract][Full Text] [Related]
30. [Adoptive immunotherapy in experimental brain tumor in rats--induction of LAK cells and their biological characteristic].
Takai N; Tanaka R; Yoshida S; Hara N; Saito T
No To Shinkei; 1987 Sep; 39(9):879-84. PubMed ID: 3500734
[TBL] [Abstract][Full Text] [Related]
31. [Meningeal gliomatosis models as a chemosensitivity assay system].
Yoshida T; Shimizu K; Ushio Y; Hayakawa T; Mogami H; Nakata Y; Sakamoto Y
Gan To Kagaku Ryoho; 1984 Mar; 11(3):458-63. PubMed ID: 6584085
[TBL] [Abstract][Full Text] [Related]
32. [Possibility of overcoming ACNU resistance in ACNU-resistant sublines of rat brain tumors in vitro by a calmodulin inhibitor].
Yoshida T; Shimizu K; Mogami H; Sakamoto Y; Egawa T
No Shinkei Geka; 1987 Feb; 15(2):143-9. PubMed ID: 3470626
[TBL] [Abstract][Full Text] [Related]
33. Adoptive immunotherapy of malignant diseases with IL-2-activated lymphocytes.
Kimoto Y; Taguchi T
Biken J; 1987 Jun; 30(2):29-38. PubMed ID: 3501954
[TBL] [Abstract][Full Text] [Related]
34. Intratumoral LAK cell and interleukin-2 therapy of human gliomas.
Barba D; Saris SC; Holder C; Rosenberg SA; Oldfield EH
J Neurosurg; 1989 Feb; 70(2):175-82. PubMed ID: 2643685
[TBL] [Abstract][Full Text] [Related]
35. [Induction of LAK cells from rat splenocytes and an anti-tumor effect of the LAK cells on the 9L-gliomas].
Imaya H
Nihon Ika Daigaku Zasshi; 1987 Oct; 54(5):479-84. PubMed ID: 3500964
[No Abstract] [Full Text] [Related]
36. [Antitumor efficacy of FK 973 on malignant glioma cells].
Shimizu K; Yamada M; Mabuchi E; Matsui Y; Tamura K; Moriuchi S; Park K; Mogami H
Gan To Kagaku Ryoho; 1989 Jul; 16(7):2367-72. PubMed ID: 2751317
[TBL] [Abstract][Full Text] [Related]
37. [Lymphokine-activated killer (LAK) adoptive immunotherapy: optimal method for large-scale LAK induction].
Nii A; Sone S; Okubo A; Fawzy F; Yanagawa H; Ogura T
Gan To Kagaku Ryoho; 1987 Jun; 14(6 Pt 1):1871-6. PubMed ID: 3496049
[TBL] [Abstract][Full Text] [Related]
38. [Mechanism of cellular resistance to ACNU in rat brain tumor cell line].
Aida T; Bodell WJ
Neurol Med Chir (Tokyo); 1986 Dec; 26(12):931-6. PubMed ID: 2438569
[No Abstract] [Full Text] [Related]
39. [Effects of anticancer drugs on multicellular spheroid of 9L rat brain tumor].
Kohno T; Matsutani M; Hoshino T; Takakura K
No To Shinkei; 1985 Oct; 37(10):991-7. PubMed ID: 3865669
[TBL] [Abstract][Full Text] [Related]
40. [In vitro chemosensitivity test with several antitumor agents against eight malignant brain tumor cell-lines].
Mabuchi E; Shimizu K; Yamada M; Moriuchi S; Park K; Tamura K; Hayakawa T; Mogami H
Gan To Kagaku Ryoho; 1991 Feb; 18(2):233-8. PubMed ID: 1992917
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
